Description |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
AJM Pharmaceuticals |
|
Product Type |
Product Size |
Tablet |
30'S |
Product Company |
Highnoon Lab |
Budesonide 400mcg, Formoterol 6mcg
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Pfizer
|
Cisplatin 50mg
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Fresenius kabi |
Cytarabine 500mg/50ml |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Al Habib Pharmaceuticals |
Doxorubicin 50mg |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Beacon pharmaceuticals
|
Nab-Paclitaxel 100mg
|
Content | Gemcitabine is a nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer. | Combivair 400mcg/6mcg rotacapsule is composed of budesonide and formoterol This medication is used for treatment of coughing, wheezing, and tightness of chest caused by asthma.
| Cisplatin is a platinum based chemotherapy agent used to treat various sarcomas, carcinomas, lymphomas, and germ cell tumors. | Cytarabine is a medication used in the management and treatment of leukemias and lymphomas. It belongs to the antimetabolic group of medications. This activity reviews the indications, action, and contraindications for cytarabine as a valuable agent in treating acute myeloid leukemia (and other leukemias. | Doxorubicin is a medication used to treat various cancers, including AIDS-associated Kaposi's Sarcoma and metastatic cancers.
Doxorubicin is a cytotoxic anthracycline antibiotic isolated from cultures of Streptomyces peucetius var. caesius along side with daunorubicin, another cytotoxic agent.
| Protein-bound paclitaxel, also known as nanoparticle albumin- bound paclitaxel or nab paclitaxel, is an injectable formulation of paclitaxel used to treat breast cancer, lung cancer, and pancreatic cancer, among others.
|
Reviews
There are no reviews yet.